These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8358518)

  • 1. Pattern of cerebral metabolic interactions in a subject with isolated amnesia at risk for Alzheimer's disease: a longitudinal evaluation.
    Pietrini P; Azari NP; Grady CL; Salerno JA; Gonzales-Aviles A; Heston LL; Pettigrew KD; Horwitz B; Haxby JV; Schapiro MB
    Dementia; 1993; 4(2):94-101. PubMed ID: 8358518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of Alzheimer's disease: a statistical approach using positron emission tomographic data.
    Azari NP; Pettigrew KD; Schapiro MB; Haxby JV; Grady CL; Pietrini P; Salerno JA; Heston LL; Rapoport SI; Horwitz B
    J Cereb Blood Flow Metab; 1993 May; 13(3):438-47. PubMed ID: 8478402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
    Drzezga A; Lautenschlager N; Siebner H; Riemenschneider M; Willoch F; Minoshima S; Schwaiger M; Kurz A
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1104-13. PubMed ID: 12764551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution PET studies in Alzheimer's disease.
    Kumar A; Schapiro MB; Grady C; Haxby JV; Wagner E; Salerno JA; Friedland RP; Rapoport SI
    Neuropsychopharmacology; 1991 Jan; 4(1):35-46. PubMed ID: 2003867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of an Alzheimer disease pattern of cerebral metabolism in Down syndrome.
    Azari NP; Pettigrew KD; Pietrini P; Horwitz B; Schapiro MB
    Dementia; 1994; 5(2):69-78. PubMed ID: 8038869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment].
    Cao Q; Jiang K; Liu Y; Zhang M; Xiao S; Zuo C; Huang H
    Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1613-6. PubMed ID: 12667368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posthypoxic amnesia: regional cerebral glucose consumption measured by positron emission tomography.
    Kuwert T; Hömberg V; Steinmetz H; Unverhau S; Langen KJ; Herzog H; Feinendegen LE
    J Neurol Sci; 1993 Aug; 118(1):10-6. PubMed ID: 8229044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished glucose transport in Alzheimer's disease: dynamic PET studies.
    Jagust WJ; Seab JP; Huesman RH; Valk PE; Mathis CA; Reed BR; Coxson PG; Budinger TF
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):323-30. PubMed ID: 1997504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a 6-month cognitive intervention program on brain metabolism in amnestic mild cognitive impairment and mild Alzheimer's disease.
    Förster S; Buschert VC; Buchholz HG; Teipel SJ; Friese U; Zach C; la Fougere C; Rominger A; Drzezga A; Hampel H; Bartenstein P; Buerger K
    J Alzheimers Dis; 2011; 25(4):695-706. PubMed ID: 21498904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal dopamine metabolism correlated with frontotemporal glucose utilization in Alzheimer's disease: a double-tracer PET study.
    Meguro K; Yamaguchi S; Itoh M; Fujiwara T; Yamadori A
    Neurology; 1997 Oct; 49(4):941-5. PubMed ID: 9339671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional cerebral glucose transport and utilization in Alzheimer's disease.
    Friedland RP; Jagust WJ; Huesman RH; Koss E; Knittel B; Mathis CA; Ober BA; Mazoyer BM; Budinger TF
    Neurology; 1989 Nov; 39(11):1427-34. PubMed ID: 2812318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease.
    Schapiro MB; Pietrini P; Grady CL; Ball MJ; DeCarli C; Kumar A; Kaye JA; Haxby JV
    J Neurol Neurosurg Psychiatry; 1993 Aug; 56(8):859-64. PubMed ID: 8350100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Measurement of regional cerebral metabolism rate of glucose in patients with Alzheimer's disease in different levels of severity].
    Xiao SF; Cao QY; Xue HB; Liu YC; Zuo CT; Jiang KD; Zhang MY
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2975-9. PubMed ID: 16324383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
    Vander Borght T; Minoshima S; Giordani B; Foster NL; Frey KA; Berent S; Albin RL; Koeppe RA; Kuhl DE
    J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral metabolism as measured with positron emission tomography (PET) and [18F] 2-deoxy-D-glucose: healthy aging, Alzheimer's disease and Down syndrome.
    Cutler NR
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):309-21. PubMed ID: 2948218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease.
    Haxby JV; Duara R; Grady CL; Cutler NR; Rapoport SI
    J Cereb Blood Flow Metab; 1985 Jun; 5(2):193-200. PubMed ID: 3988821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory: findings from the Alzheimer's Disease Neuroimaging Initiative.
    Koppel J; Sunday S; Goldberg TE; Davies P; Christen E; Greenwald BS;
    Am J Geriatr Psychiatry; 2014 Jul; 22(7):698-707. PubMed ID: 23672944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired metabolic activation in Alzheimer's disease: a PET study during continuous visual recognition.
    Kessler J; Herholz K; Grond M; Heiss WD
    Neuropsychologia; 1991; 29(3):229-43. PubMed ID: 2057055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.